Related Experiment Video
Updated: Mar 13, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Deletion of protein kinase C-ε attenuates mitochondrial dysfunction and ameliorates ischemic renal injury
Grazyna Nowak1, Diana Takacsova-Bakajsova2, Judit Megyesi3
1Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas; and gnowak@uams.edu.
Abstract:
Previously, we documented that activation of protein kinase C-ε (PKC-ε) mediates mitochondrial dysfunction in cultured renal proximal tubule cells (RPTC). This study tested whether deletion of PKC-ε decreases dysfunction of renal cortical mitochondria and improves kidney function after renal ischemia. PKC-ε levels in mitochondria of ischemic kidneys increased 24 h after ischemia. Complex I- and complex II-coupled state 3 respirations were reduced 44 and 27%, respectively, in wild-type (WT) but unchanged and increased in PKC-ε-deficient (KO) mice after ischemia. Respiratory control ratio coupled to glutamate/malate oxidation decreased 50% in WT but not in KO mice. Activities of complexes I, III, and IV were decreased 59, 89, and 61%, respectively, in WT but not in KO ischemic kidneys. Proteomics revealed increases in levels of ATP synthase (α-subunit), complexes I and III, cytochrome oxidase, α-ketoglutarate dehydrogenase, and thioredoxin-dependent peroxide reductase after ischemia in KO but not in WT animals. PKC-ε deletion prevented ischemia-induced increases in oxidant production. Plasma creatinine levels increased 12-fold in WT and 3-fold in KO ischemic mice. PKC-ε deletion reduced tubular necrosis, brush border loss, and distal segment damage in ischemic kidneys. PKC-ε activation in hypoxic RPTC in primary culture exacerbated, whereas PKC-ε inhibition reduced, decreases in: 1) complex I- and complex II-coupled state 3 respirations and 2) activities of complexes I, III, and IV. We conclude that PKC-ε activation mediates 1) dysfunction of complexes I and III of the respiratory chain, 2) oxidant production, 3) morphological damage to the kidney, and 4) decreases in renal functions after ischemia.
Insights
Deleting protein kinase C-epsilon (PKC-ε) protects kidney mitochondria from ischemia-induced dysfunction and preserves renal function. This highlights PKC-ε as a key factor in kidney injury after ischemia.
Area of Science:
- Nephrology
- Mitochondrial Biology
- Biochemistry
Background:
- Protein kinase C-epsilon (PKC-ε) activation is implicated in mitochondrial dysfunction in renal proximal tubule cells (RPTC).
- The role of PKC-ε in overall kidney function following ischemic injury remains to be fully elucidated.
Purpose of the Study:
- To investigate the impact of PKC-ε deletion on renal cortical mitochondrial function and kidney function after ischemia.
- To determine if inhibiting PKC-ε can mitigate ischemia-reperfusion injury in the kidneys.
Main Methods:
- Utilized wild-type (WT) and PKC-ε-deficient (KO) mouse models subjected to renal ischemia.
- Assessed mitochondrial respiration (complex I and II coupling, respiratory control ratio), enzyme activities (complexes I, III, IV), oxidant production, and plasma creatinine levels.
- Performed proteomics analysis and histological examination of kidney tissues; conducted in vitro studies using hypoxic RPTC.
Main Results:
- PKC-ε deletion preserved mitochondrial respiration and enzyme activities in ischemic kidneys compared to WT.
- PKC-ε deficiency reduced ischemia-induced oxidant production and attenuated increases in plasma creatinine.
- Histological analysis showed reduced tubular necrosis and damage in KO mice; in vitro studies confirmed PKC-ε's detrimental role.
Conclusions:
- PKC-ε activation is a critical mediator of mitochondrial dysfunction, specifically affecting respiratory chain complexes I and III, and oxidant production during renal ischemia.
- Deletion of PKC-ε significantly protects against ischemia-induced kidney damage and functional decline.
- Targeting PKC-ε represents a potential therapeutic strategy for preventing or treating acute kidney injury.

